BicycleTx Limited
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, BicycleTx Limited sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
BicycleTx Limited: 7 sponsored US clinical trials, 4 recruiting.
BicycleTx Limited sponsors 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Small Cell Lung Cancer, with 2 trials.
Upper-quartile sponsor footprint
BicycleTx Limited sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
A Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07450859
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
NCT06933329
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
NCT06840483
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
NCT06225596
Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression
NCT05163041
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
NCT04561362
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
NCT04180371
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 4 |
Therapeutic Areas
What is open in the BicycleTx Limited pipeline
4 recruiting of 7 indexed (57% open).
Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Non-Small Cell Lung Cancer (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
BicycleTx Limited: open-pipeline peers nationwide
Peers matched on 7 registered trials and 57% open enrollment, not the therapeutic-area sidebar.
BicycleTx Limited sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 57% open enrollment (± trial volume)
- Alimentiv · 57% recruiting · 7 trials
- Aura Biosciences · 57% recruiting · 7 trials
- Binghamton University · 57% recruiting · 7 trials
- Colorado Prevention Center · 57% recruiting · 7 trials
Related
What to do with this BicycleTx Limited page
7 registered trials is a research-attention snapshot, not an endorsement of BicycleTx Limited or any single study.
- 4 of BicycleTx Limited's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Non-Small Cell Lung Cancer is the condition BicycleTx Limited studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Small Cell Lung Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
BicycleTx Limited pipeline card: 7 registered trials from official public datasets.Report a data error.